Globus Medical, Inc. (GMED) Q2 2017 Earnings Results

Globus Medical Beats on EPS, Stock Down 0.94%

Globus Medical reported an EPS of $0.32, which was slightly above expectations. However, the stock reacted negatively, declining by 0.94%. The lack of revenue data and management commentary may have contributed to investor uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.32	N/A	+3.36%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Globus Medical Beats on EPS, Stock Down 0.94%

Key numbers

Management commentary

Globus Medical, Inc.

More earnings this week

Globus Medical Beats on EPS, Stock Down 0.94%

Key numbers

Management commentary